Rifampicin Price Trend and Forecast

Regional Price Overview

Get the latest insights on price movement and trend analysis of Rifampicin in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).

Rifampicin Price Trend for the Second Half of 2023

Rifampicin, known for its efficacy against tuberculosis and other bacterial infections, propels demand, especially in regions with high prevalence rates. Moreover, the rise in multidrug-resistant strains necessitates its use as a readily available treatment option.

Rifampicin Price Chart

Rifampicin Price Trends and Forecast

Please Login or Subscribe to Access the Rifampicin Price Chart Data

Government initiatives for tuberculosis control programs and increased healthcare expenditure further boost market growth. Additionally, the expansion of pharmaceutical manufacturing capacities and the development of generic formulations contribute to Rifampicin's accessibility and affordability and play a significant role in driving its market expansion.

In the H2 of 2023, the fluctuations in the market came in the form of the oscillations observed in the downstream pharmaceutical industries. Throughout the majority of the third quarter, the prices of the drugs inclined gradually, but in India, after the announcement of the capping of drug prices in order to keep them relevant for the general public, the downfall of the pharmaceutical industry started.

The producers of rifampicin and others had to revisit their production strategies, and thus, even by the end of the year, the market showcased no significant improvement in its dynamics and price trend. Further, the loss of imports and disruption of Red Sea routes also had an adverse effect on the overall movement of the rifampicin price trend.

Analyst Insight

According to Procurement Resource, the price trend of Rifampicin is expected to be driven by the demand from the downstream industries as well as the policies adopted by the government particularly in the Asian countries.

Rifampicin Price Trend for the First Half of 2023

Rifampicin is an antibiotic drug that is extensively used to aid TB (Tuberculosis). The Rifampicin prices showed a rapid rise over the discussed period of H1 2023. The prices had been rising for most pharmaceutical drugs since the onset of Covid 19 pandemic as globally, the demands surged overnight, but the disrupted supply chains made the transportation and procurement processes difficult.

Also, the manufacturing countries restricted the supplies to ensure domestic medicine security first. But as the restrictions are over now in most parts of the world, the prices were expected to go back to normal; however, the opposite is happening. The prices have doubled compared to the pre-pandemic levels.

The biggest driver behind the price surge is the rise in raw material API costs. As India and China account for more than 70% of global generic drug manufacturing, a price surge in this region had an impact on global Rifampicin prices. India is the key manufacturer but is almost completely dependent on Rifampicin’s active pharmaceutical ingredients in China. As China raised the API prices, the Rifampicin prices also rose.

Analyst Insight

According to Procurement Resource, the price trend for Rifampicin are likely to exhibit positive projections as the prices are likely to rise further, given the actively rising manufacturing costs.

Procurement Resource provides latest prices of Rifampicin. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.

Sample Dashboard

Please Login or Subscribe to explore our dashboard.


Rifampin, often known as rifampicin, is a macrocyclic antibiotic having significant action against mycobacteria that is frequently used in conjunction with other medications to treat tuberculosis. A semi-synthetic antibiotic produced from Amycolatopsis rifamycinica, rifampicin is a member of the rifamycin family.

As an EC (RNA polymerase) inhibitor, DNA synthesis inhibitor, antitubercular agent, leprostatic drug, Escherichia coli metabolite, protein synthesis inhibitor, neuroprotective agent, angiogenesis inhibitor, pregnancy X receptor agonist, antineoplastic agent, antiamoebic agent, and geroprotector, it also plays these other roles.

Product Details

Report Features Details
Product Name Rifampicin
HS CODE 30049057
CAS Number 13292-46-1
Industrial Uses Antibacterial medicine
Chemical Formula C43H58N4O12
Synonyms rifampin, Rifadin
Molecular Weight 822.9 g/mol
Supplier Database Wellona Pharma, AVANSCURE LIFESCIENCES PVT. LTD, Hebei Xingang Pharmaceutical Co., Ltd., Mercator Pharmaceutical Solutions
Region/Countries Covered Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Iran, Thailand, South Korea, Iraq, Saudi Arabia, Malaysia, Nepal, Taiwan, Sri Lanka, UAE, Israel, Hongkong, Singapore, Oman, Kuwait, Qatar, Australia, and New Zealand

Europe: Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece

North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru

Africa: South Africa, Nigeria, Egypt, Algeria, Morocco
Currency US$ (Data can also be provided in local currency)
Supplier Database Availability Yes
Customization Scope The report can be customized as per the requirements of  the customer
Post-Sale Analyst Support 360-degree analyst support after report delivery

Note: Our supplier search experts can assist your procurement teams in compiling and validating a list of suppliers indicating they have products, services, and capabilities that meet your company's needs.

Production Processes

  • Production of Rifampicin from Mixed Carbon Source

In this procedure, a Nocardia mediterranei culture is utilised to inoculate a fermentation media made of starch, glucose, starch from soybeans, peanut meal, and other ingredients. The result of the fermentation is rifamycin B, which is then transformed into rifamycin-O, rifamycin-S, rifamycin SV, and lastly rifampicin.


The displayed pricing data is derived through weighted average purchase price, including contract and spot transactions at the specified locations unless otherwise stated. The information provided comes from the compilation and processing of commercial data officially reported for each nation (i.e. government agencies, external trade bodies, and industry publications).

Assistance from Experts

Procurement Resource is a one-stop solution for businesses aiming at the best industry insights and market evaluation in the arena of procurement. Our team of market leaders covers all the facets of procurement strategies with its holistic industry reports, extensive production cost and pre-feasibility insights, and price trends dynamics impacting the cost trajectories of the plethora of products encompassing various industries. With the best analysis of the market trends and comprehensive consulting in light of the best strategic footstep, Procurement Resource got all that it takes.

Client's Satisfaction

Procurement Resource has made a mark for itself in terms of its rigorous assistance to its clientele. Our experienced panel of experts leave no stone unturned in ensuring the expertise at every step of our clients' strategic procurement journey. Our prompt assistance, prudential analysis, and pragmatic tactics considering the best procurement move for industries are all that sets us apart. We at Procurement Resource value our clients, which our clients vouch for.

Assured Quality

Expertise, judiciousness, and expedience are the crucial aspects of our modus operandi at Procurement Resource. Quality is non-negotiable, and we don't compromise on that. Our best-in-class solutions, elaborative consulting substantiated by exhaustive evaluation, and fool-proof reports have led us to come this far, making us the ‘numero uno' in the domain of procurement. Be it exclusive qualitative research or assiduous quantitative research methodologies, our high quality of work is what our clients swear by.

Table Of Contents

Our Clients


Get in Touch With Us


Phone:+1 307 363 1045


Phone: +91 1203185500


Phone: +44 7537 132103

Email: sales@procurementresource.com


Get latest News About Procurement Resource
Subscribe for news

This site uses cookies (including third-party cookies) to record user’s preferences. See our Privacy PolicyFor more.